학술논문
LBA 2 Everolimus plus aromatase inhibitors vs aromatase inhibitors as maintenance therapy after first-line chemotherapy in HR+/HER2- metastatic breast cancer: Final results of the phase III randomized MAIN-A trial.
Document Type
Article
Author
Source
Subject
*METASTATIC breast cancer
*AROMATASE inhibitors
*CANCER chemotherapy
*EVEROLIMUS
*ONCOLOGY
*
*
*
*
Language
ISSN
0923-7534